SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-16-745144
Filing Date
2016-10-24
Accepted
2016-10-24 16:33:54
Documents
3
Period of Report
2016-10-24
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d269710d8k.htm 8-K 19994
2 EX-99.1 d269710dex991.htm EX-99.1 8598
3 GRAPHIC g269710g69a12.jpg GRAPHIC 4319
  Complete submission text file 0001193125-16-745144.txt   35839
Mailing Address 2200 PENNSYLVANIA AVE NW SUITE 300E WASHINGTON DC 20037
Business Address 2200 PENNSYLVANIA AVE NW SUITE 300E WASHINGTON DC 20037 202-734-3400
Vanda Pharmaceuticals Inc. (Filer) CIK: 0001347178 (see all company filings)

IRS No.: 030491827 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-34186 | Film No.: 161948333
SIC: 2834 Pharmaceutical Preparations